Article info
PDFNeurological rarities
Congenital myasthenic syndrome from a MUSK gene mutation
- Correspondence to Dr Antonia McLean, Neurology, Cairns Hospital, Cairns North, Queensland, 4870, Australia; antonia.mclean2{at}health.qld.gov.au
Citation
Congenital myasthenic syndrome from a MUSK gene mutation
Publication history
- Accepted October 31, 2023
- First published November 20, 2023.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- Clinical features of congenital myasthenic syndrome due to mutations in DPAGT1
- Myasthenia and related disorders of the neuromuscular junction
- A ‘limb-girdle muscular dystrophy’ responsive to asthma therapy
- Congenital familial myasthenic syndromes: disease and course in an affected dizygotic twin pair
- Clinical features of the myasthenic syndrome arising from mutations in GMPPB
- Congenital myasthenic syndromes: an update
- Homozygous C-terminal loss-of-function NaV1.4 variant in a patient with congenital myasthenic syndrome
- Patients with a phenotype consistent with facioscapulohumeral muscular dystrophy display genetic and epigenetic heterogeneity
- Genetic neurological channelopathies: molecular genetics and clinical phenotypes
- Obstructive sleep apnoea and hypoventilation in an adult with congenital myasthenic syndrome